Skip to main content
    K

    Kestra Medical Technologies, Ltd. Common Stock (KMTS)

    Official site

    HEALTHCARE • MEDICAL INSTRUMENTS & SUPPLIES • NASDAQ

    $28.80
    +0.27 (+0.95%)

    Market Cap: $1.70B

    Last updated: Nov 06, 2026 at 4:42 PM ET

    Earnings

    Performance (10Y)

    Beat Rate
    43%(3/7)
    Avg Surprise
    -16.28%

    Upcoming Estimates

    Period ending Oct 31, 2026
    EPS Consensus$-0.60
    Range$-0.61 - $-0.60
    2 analysts
    EPS Revisions
    2
    0
    7d
    2
    0
    30d
    EPS Estimate DriftChange to current
    90d ago$-0.55-11.0%
    60d ago$-0.61+1.6%
    30d ago$-0.61+1.6%
    7d ago$-0.600.0%
    Current$-0.60
    Revenue Consensus
    $32M
    Range$32M - $33M
    9 analysts
    Period ending Jan 31, 2027
    EPS Consensus$-0.57
    Range$-0.58 - $-0.57
    2 analysts
    EPS RevisionsNo revisions (7d)
    0
    1
    30d
    EPS Estimate DriftChange to current
    90d ago$-0.55-4.5%
    60d ago$-0.56-1.8%
    30d ago$-0.56-1.8%
    7d ago$-0.570.0%
    Current$-0.57
    Revenue Consensus
    $35M
    Range$35M - $36M
    9 analysts
    PeriodReportedEst.RangeSurpriseB/MAnalystsRevisionsYoY
    Apr 27EST
    		-$-0.65$-0.66 - $-0.64--2--
    Jan 27EST
    		-$-0.57$-0.58 - $-0.57--2
    0
    1
    30d
    		-
    Oct 26EST
    		-$-0.60$-0.61 - $-0.60--2
    2
    0
    30d
    		-
    Jul 26
    Reported Sep 14
    		$-0.75$-0.61$-0.61 - $-0.60-22.95%Miss2
    0
    2
    30d
    		-108.3%
    Apr 26
    Reported Jul 14
    		$-0.67$-0.59$-0.61 - $-0.55-13.56%Miss2
    1
    1
    30d
    		+36.8%
    Jan 26
    Reported Mar 17
    		$-0.40$-0.60$-0.60 - $-0.60+33.33%Beat2
    0
    3
    30d
    		+66.1%
    Oct 25
    Reported Dec 11
    		$-0.45$-0.56-+19.64%Beat---
    Jul 25
    Reported Sep 11
    		$-0.36N/A-+53.85%Beat5
    No revisions (30d)
    		-
    Apr 25
    Reported Jul 17
    		$-1.06$-0.53$-0.65 - $-0.46-99.91%Miss5
    No revisions (30d)
    		-
    Jan 25
    Reported Apr 14
    		$-1.18$-0.64--84.38%Miss---

    Key Metrics

    Valuation
    P/E Ratio-12.69EV/EBITDAN/A
    Price/FCFN/AFCF YieldN/A
    Profitability
    Profit Margin-140.40%Operating Margin-121.60%
    ROE-73.70%ROIC-48.84%
    Financial Health
    Debt/Equity0.33xInterest Coverage-10.38x
    Current Ratio4.69xQuick Ratio4.53x
    Trading Statistics
    BetaN/AAvg Volume506.74K
    52-Week High$31.9152-Week Low$17.34

    Technical Indicators Dashboard

    Moving Averages

    SMA 10$29.62
    SMA 20$28.68
    SMA 50$26.96
    SMA 200$23.96
    EMA 10$29.22
    EMA 20$28.75
    EMA 50$27.49
    EMA 200$24.81

    MACD

    Line: 0.69Signal: 0.79Hist: -0.10

    ADX

    ADX: 18.4+DI: 20.0-DI: 18.1

    Aroon & PSAR

    Aroon Up92.0
    Aroon Down16.0
    PSAR$31.82

    Bollinger Bands

    Upper Band$31.36
    Lower Band$25.99
    %B Position1873%(Upper)
    Band Width0.52

    RSI (14-Day)

    Neutral
    51.7

    Momentum Oscillators

    Stoch %K48.7
    Stoch %D58.6
    Williams %R-60.6
    ROC (10d)0.1%
    Momentum0.04
    CCI (20d)-2.9
    MFI (14d)64.6

    Volatility Measures

    ATR (14d)$1.78(6.2%)
    StdDev (20d)1.34
    Hist Vol74.2%(High)

    Volume Flow

    VWAP$28.67
    OBV11.4M
    AD Line2.1M
    CMF (20d)-0.123

    Volume Metrics

    Avg Vol (20d)526.1K
    Vol Ratio0.7x
    VWMA (20d)$29.04

    Pivot Points

    R3$34.94
    R2$33.32
    R1$30.92
    Pivot Point$29.30
    S1$26.90
    S2$25.28
    S3$22.88

    Advanced Oscillators

    TSI11.37
    Ultimate Osc40.3
    KST122.12

    Financial Data

    QuarterJul 2026Jan 2026Oct 2025Jul 2025Apr 2025Jan 2025Oct 2024Jul 2024Apr 2024Jan 2024Oct 2023Jul 2023
    Total Revenue$30.97M$24.55M$22.57M$19.37M$2.79M$15.09M$14.71M$12.78M$10.05M$8.28M$14.71M$12.78M
    Cost of Revenue$13.47M$11.65M$11.14M$10.52M$5.40M$8.54M$8.88M$8.58M$8.66M$7.40M$8.88M$8.58M
    Gross Profit$17.50M$12.91M$11.42M$8.85M$-2,612,000$6.55M$5.83M$4.20M$1.40M$880,000$5.83M$4.20M
    Operating Expenses$55.16M$47.67M$43.18M$37.73M$22.53M$27.15M$24.96M$22.63M$21.75M$20.83M$24.96M$22.63M
    R&D$6.80M$4.97M$4.88M$4.00M$3.42M$3.35M$3.51M$3.40M$3.82M$3.73M$3.51M$3.40M
    SG&A$48.36M$42.70M$38.30M$33.73M$19.11M$23.80M$21.45M$19.23M$17.93M$17.09M$21.45M$19.23M
    Operating Income$-37,657,000$-34,765,000$-31,755,000$-28,878,000$-25,144,000$-20,601,000$-19,134,000$-18,431,000$-20,349,000$-19,946,000$-19,134,000$-18,431,000
    Interest Income$2.13M$2.16M$1.80M$2.17M$-1,392,000$628,000$878,000$37,000$0$0$878,000$37,000
    Interest Expense$8.23M$1.89M$1.90M$1.91M$2.14M$1.78M$2.32M$1.87M$1.94M$1.65M$2.32M$1.87M
    Income Before Tax$-44,037,000$-34,131,000$-32,751,000$-25,793,000$-33,394,000$-21,741,000$-20,613,000$-20,316,000$-22,311,000$-21,605,000$-20,613,000$-20,316,000
    Income Tax Expense$50,000$35,000$34,000$33,000$50,000$18,000$8,000$7,000$-27,000$14,000$8,000$7,000
    Net Income$-44,087,000$-34,166,000$-32,785,000$-25,826,000$-33,694,000$-21,509,000$-20,368,000$-19,884,000$-22,284,000$-21,619,000$-20,368,000$-19,884,000
    EBITDA$-35,747,000$-34,406,000$-29,805,000$-23,551,000$-27,659,000$-18,761,000$-16,644,000$-15,904,000$-16,874,000$-19,954,000$-16,644,000$-15,904,000
    EBIT$-37,929,000$-34,406,000$-32,646,000$-26,048,000$-29,864,000$-20,586,000$-19,174,000$-18,479,000$-20,376,000$-19,954,000$-19,174,000$-18,479,000
    * Some calculated fields are derived from available data when not provided by source

    Related GNG Research

    No research available

    Be the first to write about KMTS

    News

    Form 4 Kestra Medical Technologies Inc: Timothy P. Moran (Chief Business Officer) For: 3 November

    This article reports on a Form 4 filing for Kestra Medical Technologies Inc., specifically detailing a transaction by Timothy P. Moran, the Chief Business Officer...

    Investing.com Canada•11/5/26•Neutral

    Form 4 Kestra Medical Technologies Inc: Vaseem Mahboob (CFO) For: 27 October

    This article reports on a Form 4 filing for Kestra Medical Technologies Inc., detailing an insider transaction by its CFO, Vaseem Mahboob...

    Investing.com UK•11/4/26•Neutral

    Kestra Medical Officer Timothy P. Moran Announces Intent to Sell 3,192 Shares

    Timothy P. Moran, an officer at Kestra Medical Technologies, Ltd., has filed a Form 144 notice to sell 3,192 shares of common stock. These shares, valued at $94,351.63...

    Kalkine Media•11/4/26•Somewhat-Bearish

    Kestra Medical Technologies (KMTS) Draws Valuation Focus, Is The Stock Fully Valued?

    Kestra Medical Technologies (KMTS) is drawing valuation attention, with its stock trading slightly below the average analyst price target of $30. While considered "ABOUT RIGHT" on its fair value narrative due...

    Simply Wall St•11/2/26•Neutral

    Kestra Medical Technologies, Ltd. (KMTS) Seasonal returns chart - Yahoo Finance

    The article provides a seasonal returns chart for Kestra Medical Technologies, Ltd. (KMTS), showing its average monthly price return from 2025 to 2026. As of the latest update, KMTS stock is trading at $30.05...

    Yahoo Finance Singapore•10/31/26•Somewhat-Bullish

    KMTS Valuation and Fair Value

    P/E
    -12.7x
    P/B
    7.6x
    See GNG's fair value

    KMTS Profitability: Margins, ROIC and FCF

    Gross margin
    53.9%
    Operating margin
    -121.6%
    Net margin
    -140.4%
    ROIC
    -48.8%
    ROE
    -73.7%

    KMTS Competitors

    CompanyTicker
    Stoke Therapeutics IncSTOK
    Healthcare Services Group IncHCSG
    Novocure LtdNVCR
    Zenas BioPharma, Inc. Common StockZBIO
    Azenta IncAZTA
    Personalis IncPSNL
    Intellia Therapeutics IncNTLA
    Forte Biosciences IncFBRX

    Sector: Healthcare

    KMTS Analyst Ratings

    Consensus
    Buy
    Analysts
    8
    Strong Buy
    2
    Buy
    5
    Hold
    1
    Sell
    0
    Strong Sell
    0

    KMTS Bull Case vs Bear Case

    Bull case

    • KMTS grew quarterly revenue 59.9% year over year.
    • 87.5% of KMTS's analyst ratings are Buy or Strong Buy.

    Bear case

    • KMTS has a -140.4% net profit margin.

    KMTS Earnings: Beat Rate and Next Report

    Beat rate
    3 of 7 quarters (42.9%)
    Average surprise
    -16.3%
    EPS estimate (fiscal period ending Oct 31, 2026)
    $-0.60
    Estimate revisions (30 days, fiscal period ending Oct 31, 2026)
    2 up, 0 down

    KMTS Earnings Date

    KMTS reports Dec 11, 2026. The date is estimated.

    KMTS Earnings Call

    The latest KMTS earnings call transcript on file is labeled 2026Q3.

    Read the 2026Q3 transcript

    KMTS ETF Holders

    GNG tracks 9 ETFs that hold KMTS. The largest weights:

    1. State Street SPDR S&P Health Care Equipment ETF (XHE), 1.24% of the fund
    2. First Trust Small Cap Growth AlphaDEX Fund (FYC), 0.49% of the fund
    3. iShares U.S. Medical Devices ETF (IHI), 0.13% of the fund
    4. iShares Russell 2000 ETF (IWM), 0.01% of the fund
    5. Vanguard Health Care Index Fund ETF Shares (VHT), 0.01% of the fund
    Open the ETF Stock Exposure tool for KMTS

    Frequently Asked Questions About KMTS

    When does KMTS report earnings?

    Kestra Medical Technologies, Ltd. Common Stock (KMTS) is expected to report earnings on Dec 11, 2026.

    Does KMTS pay dividends?

    Kestra Medical Technologies, Ltd. Common Stock (KMTS) does not currently pay a regular dividend.

    What is KMTS's market cap?

    Kestra Medical Technologies, Ltd. Common Stock (KMTS) has a market capitalization of $1.70B with a current stock price of $28.80.

    Related stocks

    Sector: Healthcare

    All stocks starting with K

    Get full access to GNG Research

    Create a free account to access portfolio tracking, advanced tools, and more.

    Create Free AccountLog In